ارتباط مستويات الاندوثلين-1 وثنائي مثيل أرجينين غير المتماثل بمقاومة الانسولين فى مرضى السكري من النوع الثانى

Chai SB, Li XM, Pang YZ, Qi YF, Tang CS.

Increased plasma levels of endothelin-1 and

urotensin-II in patients with coronary heart disease.

Heart and vessels. 2010;25(2):138-43.

Palmer MK, Barter PJ, Lundman P, Nicholls SJ, Toth

PP, Karlson BW. Comparing a novel equation for

calculating low-density lipoprotein cholesterol with

the Friedewald equation: A VOYAGER analysis.

Clin. Biochem. 2019;64:24-9.

Ruze R, Xiong YC, Li JW, Zhong MW, Xu Q, Yan

ZB, et al. Sleeve gastrectomy ameliorates endothelial

function and prevents lung cancer by normalizing

endothelin-1 axis in obese and diabetic rats. World J

Gastroenterol. 2020;26(20):2599-617.

Fouda AY, Fagan SC, Ergul A. Brain Vasculature

and Cognition. Arterioscler. Thromb. Vasc. Biol.

;39(4):593-602.

Kaur R, Kaur M, Singh J. Endothelial dysfunction

and platelet hyperactivity in type 2 diabetes mellitus:

molecular insights and therapeutic strategies.

Cardiovasc. Diabetol. 2018;17(1):121.

D'Souza A, Hussain M, Howarth FC, Woods NM,

Bidasee K, Singh J. Pathogenesis and

pathophysiology of accelerated atherosclerosis in the

diabetic heart. Mol. Cell. Biochem. 2009;331(1-

:89-116.

Brownlee M. The pathobiology of diabetic

complications: a unifying mechanism. Diabetes.

;54(6):1615-25.

Maamoun H, Abdelsalam SS, Zeidan A, Korashy

HM, Agouni A. Endoplasmic Reticulum Stress: A

Critical Molecular Driver of Endothelial Dysfunction

and Cardiovascular Disturbances Associated with

Diabetes. Int. J. Mol. Sci. 2019;20(7).

Luo Z, Aslam S, Welch WJ, Wilcox CS. Activation

of nuclear factor erythroid 2-related factor 2

coordinates dimethylarginine

dimethylaminohydrolase/PPAR-gamma/endothelial

nitric oxide synthase pathways that enhance nitric

oxide generation in human glomerular endothelial

cells. Hypertension (Dallas, Tex : 1979).

;65(4):896-902.

Muniyappa R, Sowers JR. Role of insulin resistance

in endothelial dysfunction. Rev Endocr Metab

Disord. 2013;14(1):5-12.

Open Access Baghdad Science Journal P-ISSN: 2078-8665

, 19(1): 55-63 E-ISSN: 2411-7986

Patel DM, Bose M, Cooper ME. Glucose and Blood

Pressure-Dependent Pathways-The Progression of

Diabetic Kidney Disease. Int. J. Mol. Sci. 2020;21(6).

Lee W, Lee HJ, Jang HB, Kim HJ, Ban HJ, Kim KY,

et al. Asymmetric dimethylarginine (ADMA) is

identified as a potential biomarker of insulin

resistance in skeletal muscle. Sci. Rep.

;8(1):2133.

Huey-Jen Hsu S, Chen MF, Chen DR, Su TC.

Validation of the Estimation of Low-density

Lipoprotein Cholesterol by the Modified Friedewald

Equation in Ethnic Chinese Adults Living in Taiwan.

Intern Med J (Tokyo, Japan). 2015;54(18):2291-7.

Eldin Ahmed Abdelsalam K, Alobeid MEA.

Influence of Grand Multiparity on the Levels of

Insulin, Glucose and HOMA-IR in Comparison with

Nulliparity and Primiparity. Pak. J. Biol. Sci. : PJBS.

;20(1):42-6.

Duncan GE, Hutson AD, Stacpoole PW. QUICKI

does not accurately reflect changes in insulin

sensitivity with exercise training. The J. Clin.

Endocrinol. Metab. 2001;86(9):4115-9.

Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E,

Pacaud P, Loirand G. Human urotensin II–induced

contraction and arterial smooth muscle cell

proliferation are mediated by RhoA and Rho-kinase.

Circ Res. 2001;88(11):1102-4.

Ratajczak-Wrona W, Jablonska E, Antonowicz B,

Dziemianczyk D, Grabowska SZ. Levels of

biological markers of nitric oxide in serum of patients

with squamous cell carcinoma of the oral cavity. Int J

Oral Sci. 2013;5(3):141-5.

Jablonska E, Kiersnowska-Rogowska B, Ratajczak

W, Rogowski F, Sawicka-Powierza J. Reactive

oxygen and nitrogen species in the course of B-CLL.

Advances in medical sciences. 2007;52:154-8.

Kelter R. Analysis of Bayesian posterior significance

and effect size indices for the two-sample t-test to

support reproducible medical research. BMC Med

Res Methodol. 2020;20(1):88.

Rovira-Llopis S, Bañuls C, Diaz-Morales N,

Hernandez-Mijares A, Rocha M, Victor VM.

Mitochondrial dynamics in type 2 diabetes:

Pathophysiological implications. Redox Biol.

;11:637-45.

Berra-Romani R, Guzmán-Silva A, VargazGuadarrama A, Flores-Alonso JC, Alonso-Romero J,

Treviño S, et al. Type 2 Diabetes Alters Intracellular

Ca(2+) Handling in Native Endothelium of Excised

Rat Aorta. Int. J. Mol. Sci. 2019;21(1).

He Y, Ding Y, Liang B, Lin J, Kim TK, Yu H, et al.

A Systematic Study of Dysregulated MicroRNA in

Type 2 Diabetes Mellitus. Int. J. Mol. Sci.

;18(3).

Chalghoum A, Noichri Y, Karkouch I, Dandana A,

Baudin B, Jeridi G, et al. Metabolic interactions

between hyperhomocysteinemia and endothelin-1

among Tunisian patients with acute coronary

diseases. Biol. Res. 2015;48(1):32.

Inoue A, Yanagisawa M, Kimura S, Kasuya Y,

Miyauchi T, Goto K, et al. The human endothelin

family: three structurally and pharmacologically

distinct isopeptides predicted by three separate genes.

PNAS USA. 1989;86(8):2863-7.

Reynolds LJ, Credeur DP, Manrique C, Padilla J,

Fadel PJ, Thyfault JP. Obesity, type 2 diabetes, and

impaired insulin-stimulated blood flow: role of

skeletal muscle NO synthase and endothelin-1.

Physiol. (Bethesda, Md : 1985). 2017;122(1):38-47.

Pfützner A, Standl E, Hohberg C, Konrad T,

Strotmann HJ, Lübben G, et al. IRIS II study: intact

proinsulin is confirmed as a highly specific indicator

for insulin resistance in a large cross-sectional study

design. Diabetes Technol Ther. 2005;7(3):478-86.

Arunagiri A, Haataja L, Pottekat A, Pamenan F, Kim

S, Zeltser LM, et al. Proinsulin misfolding is an early

event in the progression to type 2 diabetes. eLife.

;8.

Schäfer A, Gjerga E, Welford RW, Renz I, Lehembre

F, Groenen PM, et al. Elucidating essential kinases of

endothelin signalling by logic modelling of

phosphoproteomics data. Mol. Syst. Biol.

;15(8):e8828.

Bijelic R, Balaban J, Milicevic S, Sipka SU. The

Association of Obesity and Microvascular

Complications with Glycemic Control in Patients

with Type 2 Diabetes Mellitus. Med Arch (Sarajevo,

Bosnia and Herzegovina). 2020;74(1):14-8.

Reynolds LJ, Credeur DP, Manrique C, Padilla J,

Fadel PJ, Thyfault JP. Obesity, type 2 diabetes, and

impaired insulin-stimulated blood flow: role of

skeletal muscle NO synthase and endothelin-1. J.

Appl. Physiol. 2017;122(1):38-47.

Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn

DA, Atkin SL. Biological variation of homeostasis

model assessment-derived insulin resistance in type 2

diabetes. Diabetes Care. 2002;25(11):2022-5.

El Assar M, Angulo J, Santos-Ruiz M, Ruiz de Adana

JC, Pindado ML, Sánchez-Ferrer A, et al.

Asymmetric dimethylarginine (ADMA) elevation and

arginase up-regulation contribute to endothelial

dysfunction related to insulin resistance in rats and

morbidly obese humans. J Physiol.

;594(11):3045-60.

Caplin B, Leiper J. Endogenous nitric oxide synthase

inhibitors in the biology of disease: markers,

mediators, and regulators? Arterioscler. Thromb.

Vasc. Biol. 2012;32(6):1343-53.

Anderssohn M, Schwedhelm E, Lüneburg N, Vasan

RS, Böger RH. Asymmetric dimethylarginine as a

mediator of vascular dysfunction and a marker of

cardiovascular disease and mortality: an intriguing

interaction with diabetes mellitus. Diabetes Vasc. Dis.

Res. 2010;7(2):105-18.

Beppu M, Obayashi S, Aso T, Goto M, Azuma H.

Endogenous nitric oxide synthase inhibitors in

endothelial cells, endothelin-1 within the vessel wall,

and intimal hyperplasia in perimenopausal human

uterine arteries. J. Cardiovasc. Pharmacol.

;39(2):192-200.

Enevoldsen FC, Sahana J, Wehland M, Grimm D,

Infanger M, Krüger M. Endothelin Receptor

Antagonists: Status Quo and Future Perspectives for

Targeted Therapy. Clin. Med. 2020;9(3).

Open Access Baghdad Science Journal P-ISSN: 2078-8665

, 19(1): 55-63 E-ISSN: 2411-7986

Xiong Y, Hai CX, Fang WJ, Lei YP, Li XM, Zhou

XK. Endogenous asymmetric dimethylarginine

accumulation contributes to the suppression of

myocardial mitochondrial biogenesis in type 2

diabetic rats. NUTR METAB. 2020;17:72.

Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer

A, Horrighs A, et al. Chemerin is a novel adipocytederived factor inducing insulin resistance in primary

human skeletal muscle cells. Diabetes.

;58(12):2731-40.

Burhans MS, Hagman DK, Kuzma JN, Schmidt KA,

Kratz M. Contribution of Adipose Tissue

Inflammation to the Development of Type 2 Diabetes

Mellitus. Compr.Physiol. 2018;9(1):1-58.

Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J,

Magni P, et al. Waist circumference as a vital sign in

clinical practice: a Consensus Statement from the IAS

and ICCR Working Group on Visceral Obesity. Nat.

Rev. Endocrinol. 2020;16(3):177-89.

Li YY, Shi ZM, Yu XY, Feng P, Wang XJ. Urotensin

II-induced insulin resistance is mediated by NADPH

oxidase-derived reactive oxygen species in HepG2

cells. World J Gastroenterol. 2016;22(25):5769-79.

Kaneto H, Nakatani Y, Miyatsuka T, Kawamori D,

Matsuoka TA, Matsuhisa M, et al. Possible novel

therapy for diabetes with cell-permeable JNKinhibitory peptide. Nat. Med. 2004;10(10):1128-32.

Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor

ligand human urotensin II: receptor localization in

human tissues and comparison of vasoconstrictor

responses with endothelin-1. Br. J. Pharmacol.

;131(3):441-6.